Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer. (Q46942430)
Jump to navigation
Jump to search
scientific article published on 17 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer. |
scientific article published on 17 October 2007 |
Statements
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer (English)
R Rosell
G Robinet
A Szczesna
M Constenla
B C Mennecier
W Pfeifer
K J O'Byrne
T Welte
R Kolb
R Pirker
A Chemaissani
M Perol
M R Ranson
P A Ellis
K Pilz
17 October 2007